nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0737	0.0889	CcSEcCtD
Nafarelin—Liver injury—Ramipril—type 1 diabetes mellitus	0.0442	0.0533	CcSEcCtD
Nafarelin—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0338	0.0408	CcSEcCtD
Nafarelin—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.0333	0.0401	CcSEcCtD
Nafarelin—Libido decreased—Ramipril—type 1 diabetes mellitus	0.0291	0.0351	CcSEcCtD
Nafarelin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.0276	0.0332	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.0268	0.0323	CcSEcCtD
Nafarelin—Gastritis—Ramipril—type 1 diabetes mellitus	0.0239	0.0288	CcSEcCtD
Nafarelin—Sweating increased—Ramipril—type 1 diabetes mellitus	0.0227	0.0274	CcSEcCtD
Nafarelin—Weight increased—Ramipril—type 1 diabetes mellitus	0.0212	0.0256	CcSEcCtD
Nafarelin—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0205	0.0247	CcSEcCtD
Nafarelin—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0204	0.0246	CcSEcCtD
Nafarelin—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.0202	0.0244	CcSEcCtD
Nafarelin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.0196	0.0237	CcSEcCtD
Nafarelin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.0195	0.0235	CcSEcCtD
Nafarelin—Alopecia—Ramipril—type 1 diabetes mellitus	0.0165	0.0199	CcSEcCtD
Nafarelin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.0164	0.0197	CcSEcCtD
Nafarelin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.0163	0.0196	CcSEcCtD
Nafarelin—Tension—Ramipril—type 1 diabetes mellitus	0.016	0.0192	CcSEcCtD
Nafarelin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0159	0.0192	CcSEcCtD
Nafarelin—Nervousness—Ramipril—type 1 diabetes mellitus	0.0158	0.019	CcSEcCtD
Nafarelin—Vertigo—Ramipril—type 1 diabetes mellitus	0.0146	0.0176	CcSEcCtD
Nafarelin—Palpitations—Ramipril—type 1 diabetes mellitus	0.0144	0.0173	CcSEcCtD
Nafarelin—Convulsion—Ramipril—type 1 diabetes mellitus	0.0141	0.017	CcSEcCtD
Nafarelin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.0138	0.0167	CcSEcCtD
Nafarelin—Chest pain—Ramipril—type 1 diabetes mellitus	0.0138	0.0167	CcSEcCtD
Nafarelin—Myalgia—Ramipril—type 1 diabetes mellitus	0.0138	0.0167	CcSEcCtD
Nafarelin—Oedema—Ramipril—type 1 diabetes mellitus	0.0133	0.016	CcSEcCtD
Nafarelin—Shock—Ramipril—type 1 diabetes mellitus	0.0131	0.0157	CcSEcCtD
Nafarelin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.0128	0.0155	CcSEcCtD
Nafarelin—Anorexia—Ramipril—type 1 diabetes mellitus	0.0127	0.0153	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0121	0.0146	CcSEcCtD
Nafarelin—Insomnia—Ramipril—type 1 diabetes mellitus	0.012	0.0145	CcSEcCtD
Nafarelin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.0119	0.0144	CcSEcCtD
Nafarelin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.0118	0.0143	CcSEcCtD
Nafarelin—GNRHR—GPCRs, Other—CHRM2—type 1 diabetes mellitus	0.0118	0.0693	CbGpPWpGaD
Nafarelin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0115	0.0139	CcSEcCtD
Nafarelin—Constipation—Ramipril—type 1 diabetes mellitus	0.0114	0.0137	CcSEcCtD
Nafarelin—Urticaria—Ramipril—type 1 diabetes mellitus	0.0105	0.0127	CcSEcCtD
Nafarelin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00952	0.0115	CcSEcCtD
Nafarelin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00939	0.0113	CcSEcCtD
Nafarelin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00908	0.011	CcSEcCtD
Nafarelin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00878	0.0106	CcSEcCtD
Nafarelin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00844	0.0102	CcSEcCtD
Nafarelin—Rash—Ramipril—type 1 diabetes mellitus	0.00837	0.0101	CcSEcCtD
Nafarelin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00836	0.0101	CcSEcCtD
Nafarelin—Headache—Ramipril—type 1 diabetes mellitus	0.00832	0.01	CcSEcCtD
Nafarelin—Nausea—Ramipril—type 1 diabetes mellitus	0.00788	0.00951	CcSEcCtD
Nafarelin—GNRHR—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00663	0.0389	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00597	0.035	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CCR5—type 1 diabetes mellitus	0.00562	0.0329	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.00534	0.0313	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00474	0.0278	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00468	0.0274	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00468	0.0274	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.0044	0.0258	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00437	0.0256	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00421	0.0246	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00391	0.0229	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00376	0.022	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00361	0.0211	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00357	0.0209	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00357	0.0209	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00335	0.0197	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00325	0.019	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00323	0.0189	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00282	0.0165	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.0027	0.0158	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00247	0.0145	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00246	0.0144	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.0022	0.0129	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00209	0.0123	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00205	0.012	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00204	0.0119	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00202	0.0118	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00196	0.0115	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.0019	0.0111	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00185	0.0108	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00183	0.0107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00183	0.0107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00172	0.0101	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.0017	0.00997	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00159	0.00934	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00159	0.00933	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00155	0.00905	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00145	0.00847	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.0014	0.00819	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00139	0.00815	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00127	0.00744	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00126	0.0074	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.00125	0.00732	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00125	0.0073	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.0012	0.00702	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00116	0.00682	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00116	0.0068	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00113	0.00663	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00109	0.00641	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00109	0.00638	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00108	0.00634	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00108	0.00634	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00106	0.0062	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00105	0.00618	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00102	0.00596	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.00096	0.00562	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000913	0.00535	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.0009	0.00528	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000887	0.0052	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000859	0.00503	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000854	0.005	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000854	0.005	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000818	0.00479	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000806	0.00472	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SST—type 1 diabetes mellitus	0.00075	0.00439	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000746	0.00437	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000668	0.00391	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000643	0.00377	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000625	0.00366	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000623	0.00365	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000568	0.00333	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000566	0.00331	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000545	0.00319	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00052	0.00305	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000517	0.00303	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000491	0.00288	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000483	0.00283	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000476	0.00279	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000472	0.00277	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000397	0.00233	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—INS—type 1 diabetes mellitus	0.000375	0.0022	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000363	0.00213	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000361	0.00212	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000335	0.00197	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000329	0.00193	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.00028	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000279	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000278	0.00163	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000235	0.00138	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000213	0.00125	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000164	0.000961	CbGpPWpGaD
